Related references
Note: Only part of the references are listed.CD34+cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT)
Enrico Maffini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience
Zhou Ling et al.
ANNALS OF HEMATOLOGY (2020)
Impact of Anti-CMV IgG Titers and CD34 Count Prior to Hematopoietic Stem Cell Transplantation from Alternative Donors on CMV reactivation
Leonardo Javier Arcuri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome
Mihong Choi et al.
BLOOD RESEARCH (2020)
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients
Angela Granata et al.
BONE MARROW TRANSPLANTATION (2019)
Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
Ren Lin et al.
BMC MEDICINE (2019)
Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation
Chihiro Yamamoto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology
Lanping Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
Arjun Datt Law et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
Asad Bashey et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy
Sandhya R. Panch et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Optimal Dose of Rabbit Thymoglobulin in Conditioning Regimens for Unmanipulated, Haploidentical, Hematopoietic Stem Cell Transplantation: Long-Term Outcomes of a Prospective Randomized Trial
Ying-Jun Chang et al.
CANCER (2017)
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis
P. V. O'Donnell et al.
BONE MARROW TRANSPLANTATION (2016)
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation
Ying-Jun Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
T cell costimulation blockade for hyperacute steroid refractory graft versus-host disease in children undergoing haploidentical transplantation
Sarita Rani Jaiswal et al.
TRANSPLANT IMMUNOLOGY (2016)
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning
Junichi Sugita et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults-a systematic review and meta-analysis
Udo Holtick et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Therapeutic benefits targeting B-cells in chronic graft-versus-host disease
Hideki Nakasone et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility
Andreas Kreft et al.
VIRCHOWS ARCHIV (2015)
Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation
Francis Ayuk et al.
ANNALS OF HEMATOLOGY (2014)
Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning
Kavita Raj et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide
Luca Castagna et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial
Y. Wang et al.
BONE MARROW TRANSPLANTATION (2014)
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors
A. A. Langston et al.
BONE MARROW TRANSPLANTATION (2014)
Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes
P. K. Bhamidipati et al.
BONE MARROW TRANSPLANTATION (2014)
Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases
Shigeo Fuji et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Initial Immunosuppression With or Without Basiliximab: A Comparative Study
R. M. Martin-Mateos et al.
TRANSPLANTATION PROCEEDINGS (2012)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E. D. Flowers et al.
BLOOD (2011)
From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation
Yair Reisner et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Mohamed L. Sorror et al.
BLOOD (2007)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials
M al-Jurf et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
F Aversa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
